866 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Celgene's Filing for Ozanimod Accepted for Review in US/EU http://www.zacks.com/stock/news/426482/celgenes-filing-for-ozanimod-accepted-for-review-in-us-eu?cid=CS-ZC-FT-426482 Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.
Lilly's Emgality Gets FDA Approval for Cluster Headache http://www.zacks.com/stock/news/425463/lillys-emgality-gets-fda-approval-for-cluster-headache?cid=CS-ZC-FT-425463 Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Here are the biggest analyst calls of the day: Alphabet, Big Lots, Salesforce & more https://www.cnbc.com/2019/06/03/calls-of-the-day-alphabet-big-lots-salesforce-more.html Jun 03, 2019 - Here are the biggest calls on Wall Street on Monday
TEVA: Oppenheimer ups to Outperform http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20190603072527 Jun 03, 2019 - Oppenheimer issues rating change for TEVA
Biogen Reports Interim Phase III Data on Diroximel Fumarate http://www.zacks.com/stock/news/422832/biogen-reports-interim-phase-iii-data-on-diroximel-fumarate?cid=CS-ZC-FT-422832 May 31, 2019 - Biogen (BIIB) announces new interim results from phase III EVOLVE-MS-1 study, which showed that the diroximel fumarate was generally well tolerated in people with relapsing MS.
Here are the biggest analyst calls of the day: Tesla, Apple, Citi, Verizon & more https://www.cnbc.com/2019/05/30/calls-of-the-day-tesla-apple-citi-verizon-more.html May 30, 2019 - Here are the biggest calls on Wall Street on Thursday
Jim Cramer: It's time to start buying amid market weakness, but take it slow https://www.cnbc.com/2019/05/29/jim-cramer-its-time-to-start-buying-amid-market-weakness.html May 29, 2019 - "Now that people are really freaking out ... I think it's time to start picking up stocks into weakness," Jim Cramer says.
Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target http://feeds.benzinga.com/~r/benzinga/~3/XmwzXSU6jQ4/tevas-legal-overhang-triggers-ubs-downgrade-near-halving-of-price-target May 29, 2019 -

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares have been under pressure since mid-May, when it was accused along with other generic companies for inflati

Teva: One Of My Top 5 Picks https://seekingalpha.com/article/4267040-teva-one-top-5-picks?source=feed_tag_israel May 29, 2019 - An honest appraisal of the situation facing Teva.A discussion of Teva's lawsuits.An estimation of Teva's normalized FCF.Why Teva today is dramatically undervalued.
Teva Settles With Oklahoma, Shares Fall Following Downgrade http://www.zacks.com/stock/news/421544/teva-settles-with-oklahoma-shares-fall-following-downgrade?cid=CS-ZC-FT-421544 May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.

Pages: 12345678...87

<<<Page 3>